{"entity":{"type":"insider","cik":"0001780347","url":"/insider/0001780347","json_url":"/insider/0001780347.json","name":"Longpre Lara","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2021-10-01","last":"2024-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Longpre Lara","source":"filing","n_filings":5,"first_seen":"2021-10-01","last_seen":"2024-03-18"}],"transactions":[{"id":2709106,"accession":"0001415889-24-002756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002756","line_url":"/filing/0001415889-24-002756#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF DEVELOPMENT OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":847.0,"shares_display":"847","price_per_share":26.1918,"price_display":"26.19","price_state":"stated","total_value":22184.4546,"total_display":"22,184.45","total_whole":"22,184","shares_owned_after":104407.0,"shares_owned_after_display":"104,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":2658871,"accession":"0001415889-24-000883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000883","line_url":"/filing/0001415889-24-000883#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF DEVELOPMENT OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":28.035,"price_display":"28.04","price_state":"stated","total_value":28567.665,"total_display":"28,567.66","total_whole":"28,568","shares_owned_after":105254.0,"shares_owned_after_display":"105,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":7870753,"accession":"0001209191-23-041338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041338","line_url":"/filing/0001209191-23-041338#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1004.0,"shares_display":"1,004","price_per_share":25.6466,"price_display":"25.65","price_state":"stated","total_value":25749.1864,"total_display":"25,749.19","total_whole":"25,749","shares_owned_after":105839.0,"shares_owned_after_display":"105,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-05","scope":"insider"},{"id":3085142,"accession":"0001415889-24-008316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-008316","line_url":"/filing/0001415889-24-008316#line-2","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF DEVELOPMENT OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1003.0,"shares_display":"1,003","price_per_share":20.6223,"price_display":"20.62","price_state":"stated","total_value":20684.1669,"total_display":"20,684.17","total_whole":"20,684","shares_owned_after":104369.0,"shares_owned_after_display":"104,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2024-03-18","scope":"insider"},{"id":5112999,"accession":"0001209191-21-058606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058606","line_url":"/filing/0001209191-21-058606#line-2","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":961.0,"shares_display":"961","price_per_share":19.256,"price_display":"19.26","price_state":"stated","total_value":18505.016,"total_display":"18,505.02","total_whole":"18,505","shares_owned_after":84245.0,"shares_owned_after_display":"84,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":3085139,"accession":"0001415889-24-008316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008316","line_url":"/filing/0001415889-24-008316#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780347","owner_name":"Longpre Lara","owner_display_name":"Longpre Lara","owner_url":"/insider/0001780347","role":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF DEVELOPMENT OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF DEVELOPMENT OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":965.0,"shares_display":"965","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":10267.6,"total_display":"10,267.60","total_whole":"10,268","shares_owned_after":105372.0,"shares_owned_after_display":"105,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2024-03-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Officer (CHIEF DEVELOPMENT OFFICER)","n_filings":5,"first_seen":"2021-10-01","last_seen":"2024-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780347","retrieved_at":"2026-08-22T08:23:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}